. 2021 Feb 10;2021(2):CD012882. doi: 10.1002/14651858.CD012882.pub2

8. Comparison 1 results: coverage of appropriate treatment by an iCCM provider.

Outcome	Trial ID	Study design	Preintervention coverage		Postintervention coverage		Risk ratio (95% CI)	Coverage indicators analysis summary
Outcome	Trial ID	Study design	iCCM	Control	iCCM	Control	Risk ratio (95% CI)	Coverage indicators analysis summary
Coverage of appropriate treatment for diarrhoea from an iCCM provider	Yansaneh 2014	CBA	0% (0/751)	0% (0/644)	8.7% (56/642)	0% (0/733)	128.99 (7.99 to 2083.46)	Recalculated, unadjusted results^a
Coverage of appropriate treatment for malaria from an iCCM provider	Yansaneh 2014	CBA	0% (1/1948)	0.4% (8/1819)	3.1% (45/1413)	0% (0/1863)	119.96 (7.40 to 1945.55)	Recalculated, unadjusted results^a

CBA: controlled before‐after study; CI: confidence intervals; iCCM: integrated community case management. ^aWe recalculated results for Yansaneh 2014 based un unadjusted counts (see Data extraction and management).